The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

One common symptom of multiple sclerosis (MS) is vision impairment, and it can progress to blindness in some cases. Now, researchers at the University of California, Riverside report a drug that was ...

Retinal vein occlusion (RVO) is classified into central and branch RVO, each of which is further classified into ischemic and nonischemic types. Patients often present with sudden yet painless ...

Multiple sclerosis occurs when a person’s immune system is triggered to attack the myelin sheath—a protective coating surrounding nerve cells in the central nervous system (CNS). The CNS is made up of ...

Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...

In a longitudinal cohort study, patients with multiple sclerosis underwent cognitive evaluation and magnetic resonance imaging scans at baseline and after 3 years. Memory decline was observed in ...

FAME is a dose-dependent side effect that infrequently occurs at the US Food and Drug Administration (FDA)-approved dose of 0.5 mg/day. The phase 3 FREEDOMS, [2] FREEDOMS II, [3] and TRANSFORMS [4] ...